Results 251 to 260 of about 26,895 (263)

Kidney stones and SGLT2 inhibitors

Clinical and Experimental Nephrology
Satoru Kuriyama, Kimiyoshi Ichida
openaire   +2 more sources

SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis

Clinical Therapeutics, 2016
Ronald M Goldenberg, Lori Berard, Alice Y Y Cheng   +2 more
exaly  

The expanding résumé of SGLT2 inhibitors

The Lancet Diabetes & Endocrinology, 2019
openaire   +2 more sources

SGLT2 Inhibitors and Iron

JACC: Heart Failure, 2023
openaire   +1 more source

TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity

British Journal of Pharmacology, 2011
H Tomoike
exaly  

A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery

AACE Clinical Case Reports, 2021
exaly  

Modification on the O-glucoside of Sergliflozin-A: A new strategy for SGLT2 inhibitor design

Bioorganic and Medicinal Chemistry Letters, 2016
Peng George Wang, Jie Shen
exaly  

Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials

Diabetologia, 2016
Huilin Tang, Xi Zhang, Jingjing Zhang
exaly  

SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria

Biopharmaceutics and Drug Disposition, 2014
Yukihiro Chino, Yoshishige Samukawa, Soichi Sakai   +2 more
exaly  

The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice

International Journal of Molecular Sciences, 2017
Yusuke Nakatsu, Hiroki Kokubo, Batmunkh Bumdelger   +2 more
exaly